NEW YORK, Feb. 16, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Future Infectious Disease Nucleic Acid Testing

http://www.reportlinker.com/p0773575/Future-Infectious-Disease-Nucleic-Acid-Testing.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory

This 360-page report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.

Contains 360 pages and 20 tables

Table of Contents 1. Overview

2. Major Infectious Diseases

* AIDS

O Structure and Composition

O Classification

O AIDS Origins

O Animal Lentivirus Systems

O Virus Receptors

O HIV Infections in Humans

- Pathogenesis and Pathology

O CD4T Lymphocytes and Memory Cells

O Monocytes and Macrophages

O Lymphoid Organs

O Neural Cells

O Viral Coinfections

- Clinical Findings

O Plasma Viral Load

O Pediatric AIDS

- Neurologic Disease

- Opportunistic Infections

- Cancer

O Immunity

- Virus Isolation

- Serology

- Viral Nucleic Acid/Antigen Detection

O Epidemiology

- Worldwide Spread of AIDS

- United States

- Routes of Transmission

O DNA Probes- Overview- Quantitative PCR- In Situ PCR- Needed ImprovementsO Viral Load/Drug Resistance TestingO Genotype and Phenotype TestingO Blood Banking Considerations* AdenovirusO BackgroundO Diagnostic TestsO Vaccines and DrugsO Adeno-Associated Viruses (AAV)* Anthrax/Bacillus AnthracisO BackgroundO Diagnostic TestsO Vaccines and Drugs* BabesiosisO Background* BEA and Other Bartonella DiseasesO BackgroundO Diagnostic TestsO Vaccines and Drugs* Chagas DiseaseO Background* CampylobacterO BackgroundO Diagnostic Tests- Culture IdentificationO Vaccines and Drugs* ChlamydiaO Background- Chlamydia psittaci- Chlmaydia pneumoniae- Chlamydia trachomatisO Diagnostic TestsO Vaccines and Drugs* Creutzfeldt-Jakob's DiseaseO BackgroundO Blood TransmissionO Diagnostic Tests

O Major Commercial and Academic Players

- Bayer

- Disease Sciences/Bio Tec Global

- Imperial College School of Medicine

- Ortho-Clinical Diagnostics

- Pall

- ProMetic Life Sciences

- Proteome Sciences/Idexx

- Q-One Biotech

- Serono

- U.S. Agricultural Research Service

O Drugs

O Vaccines

* Cytomegalovirus

O Background

- Chorioretinitis

- Gastrointestinal

- Central Nervous System Disease

O Diagnostic Tests

O Vaccines and Drugs

* Ebola Virus

O Background

- Epidemiology

- Clinical Syndromes

O Diagnostic Tests

O Vaccines and Drugs

* EchoVirus

O Background

- Acute Aseptic Meningitisis

- Encephalitis

- Exanthems

- Respiratory Disease

- Myopericarditis

- Neonatal Infections

O Diagnostic Tests

O Vaccines and Drugs

* Encephalitis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* EnterovirusesO BackgroundO Diagnostic Tests- Viral Isolation and Identification- Antibody TestsO Vaccines and Drugs* Epstein-Barr VirusO BackgroundO Diagnostic TestsO Vaccines and Drugs* GonorrheaO BackgroundO Diagnostic TestsO Vaccines and Drugs* HepatitisO Hepatitis AO Hepatitis B- Structure and Composition- ReplicationO Hepatitis CO Hepatitis D (Delta)O Hepatitis EO Hepatitis GO Hepatitis Infections PathologyO Clinical FindingsO Laboratory Tests- Hepatitis A- Hepatitis B- Hepatitis C- Hepatitis D- Hepatitis EO Virus-Host Immune ReactionsO Epidemiology- Hepatitis A- Hepatitis B- Hepatitis C- Hepatitis D (Delta)O Vaccines and Drugs

* Herpes Simplex Virus

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Legionella

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Lyme Disease

O Background

- Clinical Description

- Clinical Case Definition

- Laboratory Criteria for Diagnosis

- Case Classification

O Diagnostic Tests

O Vaccines and Drugs

* Malaria

* Mycoplasma

O Background

- Ureaplasma Urealyticum & Mycoplasma

Hominis

O Diagnostic Tests

O Vaccines and Drugs

* Papillomaviruses/HPV

O Background

- HPV in Cancer

- Cervical Neoplasm

O Diagnostic Tests

O Vaccines and Drugs

- Prevention

* Parvovirus B19

O Background

- Microbiology

- Epidemiology

- Clinical Syndromes

- Erythema Infectiosum (Slapped Cheek)

- Adult Polyarthropathy

- Transient Aplastic Crisis

- Transient Pancytopenia

- Red Cell Aplasia in Immunocompromised- Perinatal InfectionsO Diagnostic TestO Vaccines and Drugs* PneumoniaO BackgroundO Diagnostic TestsO Vaccines and Drugs* PolyomavirusesO BackgroundO Diagnostic TestsO Vaccines and Drugs* SalmonellosisO BackgroundO Diagnostic TestsO Vaccines and Drugs* ShigellosisO BackgroundO Diagnostic TestsO Vaccines and Drugs* StreptococciO BackgroundO Diagnostic TestsO Vaccines and Drugs- Group A Streptococci- Group B Streptococci* ToxoplasmosisO BackgroundO Diagnostic TestsO Vaccines and Drugs* TuberculosisO BackgroundO Diagnostic Tests- Microscopic Characteristics- Cultural Characteristics- Skin Tests- MDRTBO Vaccines and Drugs

* West Nile Virus

O Background

- Clinical Syndromes

O Diagnostic Tests

O Vaccines and Drugs

* Yersinia

O Background

O Diagnostic Tests

O Vaccines and Drugs

3. Antibiotic Susceptibility

List of Tables Table 1: Major Companies Developing or Marketing

AIDS NAT and other Direct

Identification Tests

Table 2: Major Companies Developing or Marketing

Adenovirus NAT and other

Direct Identification Tests

Table 3: Major Companies Developing or Marketing

Campylobacter NAT and

Other Direct Identification Tests

Table 4: Major Companies Developing or Marketing

Chlamydia NAT and other

Direct Identification Tests

Table 5: Major Companies Developing or Marketing

CMV NAT and other Direct

Identification Tests

Table 6: Major Companies Developing or Marketing

EBV NAT and other Direct

Identification Tests

Table 7: Major Companies Developing or Marketing

Gonorrhea NAT and other

Direct Identification Tests

Table 8: Major Companies Developing or Marketing

Hepatitis NAT and other

Direct Identification Tests

Table 9: Major Companies Developing or Marketing

Herpes NAT and other

Direct Identification Tests

Table 10: Major Companies Developing or Marketing

Legionella NAT and other

Direct Identification Tests

List of Tables (continued)

Table 11: Major Companies Developing or Marketing

Lyme Disease NAT

And Other Direct Identification Tests

Table 12: Major Companies Developing or Marketing

Mycoplasma NAT

And other Direct Identification Tests

Table 13: Major Companies Developing or Marketing

Papilloma Virus NAT

And Other Direct Identification Tests

Table 14: Major Companies Developing or Marketing

Pneumonia NAT

And other Direct Identification Tests

Table 15: Major Companies Developing or Marketing

Salmonella NAT

And other Direct Identification Tests

Table 16: Major Companies Developing or Marketing

Shigella NAT

And other Direct Identification Tests

Table 17: Major Companies Developing or Marketing

Streptococci NAT

And Other Direct Identification Tests

Table 18: Major Companies Developing or Marketing

Toxoplasmosis NAT

And Other Direct Identification Tests

Table 19: Major Companies Developing or Marketing

Tuberculosis NAT

And Other Direct Identification Tests

To order this report:: Future Infectious Disease Nucleic Acid Testing

More  

Market Research Report

Check our  

Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com